ML

Matthew Lee

MT Mirati Therapeutics: 3 patents #6 of 37Top 20%
AB Array Biopharma: 1 patents #29 of 63Top 50%
CF Chdi Foundation: 1 patents #5 of 21Top 25%
Overall (2022): #29,497 of 548,613Top 6%
5
Patents 2022

Issued Patents 2022

Patent #TitleCo-InventorsDate
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-11-01
11389438 Compounds for targeting mutant huntingtin protein and uses thereof Celia Dominguez, Jonathan Bard, Longbin Liu, Michael Prime, Samuel Coe 2022-07-19
11267812 KRAS G12C inhibitors John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia +10 more 2022-03-08
11248004 Substituted isoquinolines as rock kinase inhibitors Anthony Joseph Varano, Jr., Thomas P. Bobinski 2022-02-15
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-01-11